Evidence map›Paper›PMID 30270167›Full record

Trial reportThe Journal of pediatrics2019

Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome.

Jill C Handisides, Danielle Hollenbeck-Pringle, Karen Uzark, Felicia L Trachtenberg, Victoria L Pemberton, Teresa W Atz, Timothy J Bradley, Elizabeth Cappella, Sylvia De Nobele, Georgeann Keh-Teng Groh and 17 more

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Family functioning and health-related quality of life in children and young adults with Marfan syndrome.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Marfan syndrome.Nature reviews. Disease primers · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 3 countries.

Jill C HandisidesBoston Children's Hospital, Harvard Medical School, Boston, MA.
Danielle Hollenbeck-PringleNew England Research Institutes Inc., Watertown, MA.
Karen UzarkC. S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI.
Felicia L TrachtenbergNew England Research Institutes Inc., Watertown, MA.
Victoria L PembertonNational Heart, Lung, and Blood Institute, Bethesda, MD.
Teresa W AtzMedical University of South Carolina, Charleston, SC.
Timothy J BradleyThe Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Elizabeth CappellaAnn and Robert H. Lurie Children's Hospital, Chicago, IL.
Sylvia De NobeleGhent University Hospital, Ghent, Belgium.
Georgeann Keh-Teng GrohWashington University School of Medicine, St. Louis, MO.
Michelle S HamstraCincinnati Children's Hospital Medical Center, Cincinnati, OH.
Rosalind KorsinChildren's Hospital of New York, New York, NY.
Jami C LevineBoston Children's Hospital, Harvard Medical School, Boston, MA.
Bergen LindauerPrimary Children's Hospital, University of Utah, Salt Lake City, UT.
Aimee LiouTexas Children's Hospital, Houston, TX.
Meghan K Mac NealIcahn School of Medicine at Mount Sinai, New York, NY.
Larry W MarkhamThe Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN.
Tonia MorrisonChildren's Hospital of Philadelphia, Philadelphia, PA.
Kathleen A MussattoChildren's Hospital of Wisconsin, Milwaukee, WI.
Aaron K OlsonSeattle Children's Hospital, Seattle, WA.
Mary Ella M PierpontChildren's Hospital and Clinic of Minnesota, St. Paul, MN.
Reed E PyeritzThe Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Elizabeth A RadojewskiThe Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Mary J RomanWeill Cornell Medical Center, New York, NY.
Mingfen XuDuke University School of Medicine, Durham, NC.
Ronald V LacroBoston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: ron.lacro@cardio.chboston.org.
Pediatric Heart Network Investigators
University of Toronto · CABoston Children's Hospital · USMedical University of South Carolina · USMonroe Carell Jr. Children's Hospital · USNew England Research Institutes · USCincinnati Children's Hospital Medical Center · USCornell University · USIcahn School of Medicine at Mount Sinai · USNational Heart Lung and Blood Institute · USPrimary Children's Hospital · USSeattle Children's Hospital · USChildren's Hospital of Philadelphia · USChildren's Hospital of Wisconsin · USChildren’s Minnesota - St. Paul Hospital · USDuke University · USGhent University Hospital · BELurie Children's Hospital · USTexas Children's Hospital · USUniversity of Michigan · USUniversity of Pennsylvania · US

Funding

Pediatric Heart network DCCU10HL068270 · NHLBI · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MILLER, JULIE ELAINE, TRACHTENBERG, FELICIA LYNN · 2011 to 2016
$44.9M
Ventricular Volumes and Varability (VVV)U01HL068270 · NHLBI · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI SLEEPER, LYNN A · 2001 to 2010
$40.3M
MIS-C Program: Data Coordinating Center for the Pediatric Heart Network MIS-C ProgramU24HL135691 · NHLBI · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MILLER, JULIE ELAINE, TRACHTENBERG, FELICIA LYNN · 2017 to 2024
$37.9M
Pediatric Heart Network: Follow-up of the Single Ventricle Reconstruction TrialU01HL068290 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LAI, WYMAN W · 2001 to 2010
$4.1M
Pediatric Heart Disease Network: CHOP MembershipU01HL068279 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI VETTER, VICTORIA L · 2001 to 2010
$3.7M
Randomized Therapeutic Trials in Pediatric Heart DiseaseU01HL068285 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI NEWBURGER, JANE W. · 2001 to 2010
$3.4M
Randomized Clinical Trials for Pediatric Heart DiseaseU01HL068281 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SAUL, J PHILIP · 2001 to 2010
$3.2M
Clinical and genomic responses to remote ischemic preconditioningU01HL068288 · NHLBI · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI MCCRINDLE, BRIAN W · 2001 to 2010
$3.0M
Intermountain Pediatric Heart Disease Research CenterU01HL068292 · NHLBI · UNIVERSITY OF UTAH · PI MINICH, L. LUANN · 2001 to 2010
$2.7M
The Duke-UNC-CH Pediatric Cardiology Clinical CenterU01HL068269 · NHLBI · DUKE UNIVERSITY · PI LI, JENNIFER S · 2001 to 2010
$2.6M
Pediatric Heart Network Prairieland ConsortiumUG1HL135678 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CNOTA, JAMES, PAYNE, RONALD MARK · 2017 to 2023
$2.4M
Preoperative Therapy for Prevention of Postoperative Low Cardiac Output SyndromeU01HL085057 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BENSON, DUDLEY WOODROW (WOODY) · 2006 to 2010
$1.5M
NHLBI NIH HHS U01 HL068269NHLBI NIH HHS U01 HL068270NHLBI NIH HHS U01 HL068279NHLBI NIH HHS U01 HL068281NHLBI NIH HHS U01 HL068285NHLBI NIH HHS U01 HL068288NHLBI NIH HHS U01 HL068290NHLBI NIH HHS U01 HL068292NHLBI NIH HHS U01 HL085057NHLBI NIH HHS U10 HL068270NHLBI NIH HHS U24 HL135691NHLBI NIH HHS UG1 HL135678
6 · The paper itself

Abstract

objectiveTo assess health-related quality of life (HRQOL) in a large multicenter cohort of children and young adults with Marfan syndrome participating in the Pediatric Heart Network Marfan Trial. STUDY

designThe Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales were administered to 321 subjects with Marfan syndrome (5-25 years). PedsQL scores were compared with healthy population norms. The impact of treatment arm (atenolol vs losartan), severity of clinical features, and number of patient-reported symptoms on HRQOL was assessed by general linear models.

resultsMean PedsQL scores in children (5-18 years) with Marfan syndrome were lower than healthy population norms for physical (P ≤ .003) and psychosocial (P < .001) domains; mean psychosocial scores for adults (19-25 years) were greater than healthy norms (P < .001). HRQOL across multiple domains correlated inversely with frequency of patient-reported symptoms (r = 0.30-0.38, P < .0001). Those <18 years of age with neurodevelopmental disorders (mainly learning disability, attention-deficit/hyperactivity disorder) had lower mean PedsQL scores (5.5-7.4 lower, P < .04). A multivariable model found age, sex, patient-reported symptoms, and neurodevelopmental disorder to be independent predictors of HRQOL. There were no differences in HRQOL scores by treatment arm, aortic root z score, number of skeletal features, or presence of ectopia lentis.

conclusionsChildren and adolescents with Marfan syndrome were at high risk for impaired HRQOL. Patient-reported symptoms and neurodevelopmental disorder, but not treatment arm or severity of Marfan syndrome-related physical findings, were associated with lower HRQOL.

Indexed as

Quality of LifeAdolescentAdultAntihypertensive AgentsAtenololChildChild, PreschoolFemaleHealth Status IndicatorsHumansLosartanMaleMarfan SyndromePatient Reported Outcome MeasuresSeverity of Illness IndexYoung AdultAntihypertensive AgentsAtenololLosartanneurodevelopmental disorderspatient-reported symptoms

Identifiers

PMID30270167
PMCPMC6800200
OpenAlexW2892628441

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.